Feature | Implantable Cardioverter Defibrillator (ICD) | July 02, 2015

Boston Scientific Initiates Global Study of Emblem Subcutaneous Implantable Defibrillator

Study examines primary prevention in patients with low ejection fraction

Boston Scientific, Emblem, S-ICD, UNTOUCHED study, TV-ICDs, MADIT-RIT study

July 2, 2015 - Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the Emblem subcutaneous implantable defibrillator (S-ICD). The device is indicated for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function (left ventricular ejection fraction </= 35 percent).

Primary prevention patients do not have a previously documented life-threatening arrhythmic event, but are at risk of sudden cardiac death and thereby indicated to receive an implantable defibrillator. This group of patients represents the highest proportion of patients that are implanted with transvenous ICD (TV-ICDs) devices today in the United States and European Union. 

In order to further demonstrate the usefulness of the S-ICD System in this particular patient population, the UNTOUCHED study will compare outcomes during an 18-month follow-up period to objective performance criteria derived from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) study. The landmark MADIT-RIT study evaluated shock rates in 1,500 patients implanted with TV-ICD devices and is one of the largest randomized trials to assess shock reduction strategies for TV-ICD devices.

"The MADIT-RIT trial demonstrated that standardized programming using higher rate cutoffs and longer delays to therapy reduces the incidence of inappropriate shocks for TV-ICDs," said Lucas Boersma, M.D., EU principal investigator and electrophysiologist at St. Antonius Hospital, The Netherlands. "The UNTOUCHED trial will examine the incidence of all-cause shocks when using the EMBLEM S-ICD System with standardized therapy settings similar to MADIT-RIT."

The first patient enrolled in the global, multi-site, prospective, non-randomized UNTOUCHED study received an Emblem implant by Craig Barr, M.D., cardiologist at Russells Hall Hospital in Dudley, England. The study will enroll a minimum of 2,015 patients at up to 200 sites worldwide. Enrollments in the United States will begin later this summer.

"In the published data to date, we have observed S-ICD devices demonstrate comparable inappropriate shock rates for arrhythmias to TV-ICDs," said Michael Gold, M.D., Ph.D., U.S. principal investigator and chief of cardiology and the Michael E. Assey professor of medicine at Medical University of South Carolina, Charleston. "Ideally, this trial will demonstrate S-ICD devices can either meet or improve upon the inappropriate shock rates experiences with TV-ICDs in MADIT-RIT within this large patient population."

The Emblem S-ICD system received CE mark earlier this year and was approved by the U.S. Food & Drug Administration (FDA) in March of 2015. The device launched in Europe starting in May, and became commercially available in the United States in June, in preparation for a planned full U.S. launch during the third quarter of 2015.

For more information: www.bostonscientific.com

Related Content

News | Sudden Cardiac Arrest

September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment ...

Home September 13, 2021
Home
Feature | Sudden Cardiac Arrest

September 1, 2021 — The world’s first feasibility study has found that drones can be used to deliver life-saving ...

Home September 01, 2021
Home
Feature | Sudden Cardiac Arrest

May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to ...

Home May 19, 2021
Home
News | Sudden Cardiac Arrest

May 17, 2021 — In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who ...

Home May 17, 2021
Home
News | Sudden Cardiac Arrest

April 2, 2020 — Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics ...

Home April 02, 2020
Home
Feature | Sudden Cardiac Arrest

October 7, 2019 — Glynn Crawford was hospitalized at University Hospitals Ahuja Medical Center in late June/early July ...

Home October 07, 2019
Home
News | Sudden Cardiac Arrest

July 26, 2019 — Significantly more patients suffer cardiac arrests in U.S. hospitals each year than previously estimated ...

Home July 26, 2019
Home
News | Sudden Cardiac Arrest

For patients at risk for sudden cardiac arrest (SCA) who are being evaluated for a permanent implantable cardioverter ...

Home July 02, 2019
Home
News | Sudden Cardiac Arrest

March 12, 2019 – Out-of-hospital cardiac arrest was the third leading cause of “health loss due to disease” in the U.S ...

Home March 12, 2019
Home
Feature | Sudden Cardiac Arrest

Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to participate in ...

Home October 25, 2018
Home
Subscribe Now